SMRTActiv™ Technology
CuralysMD™ is powered by SMRTActiv™ Technology and formulated with colloidal oatmeal to promote barrier restoration and regulate inflammatory pathways implicated in atopic dermatitis.
Our Science
A Smarter Path to a Healthier Skin Barrier
SMRTActiv™ Technology with colloidal oatmeal is the proprietary foundation of CuralysMD™ — a science-first platform designed to deliver visible, lasting improvement in atopic dermatitis by repairing the skin barrier and rebalancing skin function at its source.
Preclinical Data
Preclinical studies of the SMRTActiv™ platform demonstrate targeted modulation of key biological pathways implicated in skin inflammation and barrier dysfunction.
Clinical Studies
CuralysMD™ was evaluated in two randomized, double-blind, vehicle-controlled clinical trials conducted in adult and pediatric patients with mild-to-moderate atopic dermatitis (AD).
Publications
As a science-first, founder-led dermaceutical platform, our work — spanning mechanistic research, clinical studies, and translational science — reflects the scientific depth and rigor underpinning CuralysMD™.
Clinical Insights. Real Solutions.
Engage with our team to explore the science behind CuralysMD™ and how our platform redefines eczema care through clinically validated barrier-first dermatology.
